Elanco Animal Health (ELAN) Enterprise Value (2017 - 2026)
Elanco Animal Health (ELAN) posted Enterprise Value of -$428.0 million for Q1 2026, up 21.47% sequentially from -$545.0 million in Q4 2025, and up 12.11% YoY from -$381.8 million in Q1 2025.
Elanco Animal Health (ELAN) Enterprise Value (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Enterprise Value for 10 years, with the latest figure at -$428.0 million in Q1 2026.
- Quarterly Enterprise Value rose 12.11% year-over-year to -$428.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$428.0 million (up 12.11% YoY) and the FY2025 annual result came in at -$545.0 million, down 16.45% from the prior year.
- Enterprise Value grew to -$428.0 million in Q1 2026 per ELAN's latest filing, from -$545.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$318.0 million in Q1 2023 and troughed at -$545.0 million in Q4 2025.
- A 5-year average of -$428.4 million and a median of -$428.0 million in 2026 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value soared 45.92% in 2022, then sank 41.16% in 2025.
- Over 5 years, Enterprise Value stood at -$345.0 million in 2022, then dropped by 2.03% to -$352.0 million in 2023, then slumped by 32.95% to -$468.0 million in 2024, then slipped by 16.45% to -$545.0 million in 2025, then increased by 21.47% to -$428.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$428.0 million, -$545.0 million, and -$505.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -530.00 Mn |
| Mar 31, 2026 | -428.00 Mn |
| Dec 31, 2025 | -545.00 Mn |
| Sep 30, 2025 | -505.00 Mn |
| Jun 30, 2025 | -539.00 Mn |
| Mar 31, 2025 | -487.00 Mn |
| Dec 31, 2024 | -468.00 Mn |
| Sep 30, 2024 | -490.00 Mn |
| Jun 30, 2024 | -416.00 Mn |
| Mar 31, 2024 | -345.00 Mn |
| Dec 31, 2023 | -352.00 Mn |
| Sep 30, 2023 | -369.00 Mn |
| Jun 30, 2023 | -367.00 Mn |
| Mar 31, 2023 | -318.00 Mn |
| Dec 31, 2022 | -345.00 Mn |
| Sep 30, 2022 | -460.00 Mn |
| Jun 30, 2022 | -507.00 Mn |
| Mar 31, 2022 | -342.00 Mn |
| Dec 31, 2021 | -638.00 Mn |
| Sep 30, 2021 | -453.00 Mn |